Rapid characterization of drug-drug interaction in plasma protein binding using a surface plasmon resonance biosensor

Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 2, 2008, Pages 120-127

  Kuroda, Yukihiro ^a,b   Saito, Madoka ^b   Sakai, Harumi ^a   Yamaoka, Takashi ^a  

^a Sumika Chemicals Analysis Service Ltd   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Drug drug interaction; High throughput screening; Human serum albumin; Plasma protein binding; Surface plasmon resonance

Indexed keywords

COUMARIN; HUMAN SERUM ALBUMIN; IBUPROFEN; NAPROXEN; PHENYLBUTAZONE; TRYPTOPHAN; WARFARIN; PLASMA PROTEIN;

ALLOSTERISM; ARTICLE; BINDING COMPETITION; BIOSENSOR; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG PROTEIN BINDING; DRUG RESEARCH; HIGH THROUGHPUT SCREENING; HUMAN; INHIBITION KINETICS; PLASMA PROTEIN BINDING; REGRESSION ANALYSIS; SURFACE PLASMON RESONANCE; BINDING SITE; DRUG INTERACTION; GENETIC PROCEDURES; METABOLISM; METHODOLOGY; PROTEIN BINDING;

BINDING SITES; BIOSENSING TECHNIQUES; BLOOD PROTEINS; DRUG INTERACTIONS; HUMANS; NAPROXEN; PHENYLBUTAZONE; PROTEIN BINDING; SURFACE PLASMON RESONANCE; WARFARIN;

EID: 43749113794     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.23.120     Document Type: Article

References (16)

1. Kragh-Hansen, U.: Relations between high-affinity binding sites of markers for binding regions on human serum albumin. Biochem. J., 225: 629-638 (1985).
2. Chen, J. and Hage, D.S.: Quantitative analysis of allosteric drugprotein binding by biointeraction chromatography. Nature Biotech., 22(11): 1445-1448 (2004).
3. Chattopadhyay, A., Tian, T., Kortum, L. and Hage, D. S.: Development of tryptophan modified human serum albumin columns for site-specific studies of drug protein interactions by high-performance affinity chromatography. J. Chromatogr. B, 715: 183-190 (1998).
4. Fitos, I., Visy, J., Simonyi, M. and Hermansson, J.: Stereoselective Allosteric Binding Interaction on Human Serum Albumin between Ibuprofen and Lorazepam Acetate. Chrality, 11: 115-120 (1999).
5. Day, Y. S. N. and Myszka, D. G.: Characterizing a Drug's Primary Binding Site on Albumin. J. Pharm. Sci., 92: 333-343 (2003).
6. Rich, R. L., Day, Y. S. N., Morton, T. A. and Myszka, D. G.: High-Resolution and High-Throughput Protocols for Measuring Drug/Human Serum Albumin Interactions Using BIACORE. Anal. Biochem., 296: 197-207 (2001).
7. Frostell-Karlsson, Å., Remaeus, A., Roos, H., Andersson, K., Borg, P., Häamäaläaimen, M., Karlsson, R.: Bisensor Analysis of the Interaction between Immobilized Human Serum Albumin and Drug Compounds for Prediction of Human Serum Albumin Binding Levels. J. Med. Chem., 43: 1986-1992 (2000).
8. Zhang, J. and Musson D. G.: Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization. J. Chromatogr. B., 843: 47-56 (2006).
9. Zhang, Z. Y., King, B. M. and Wong, Y. N.: Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies. Anal. Biochem., 298: 40-49 (2001).
10. Miao, X., Koenig, B. G. and Metcalfe, C. D.: Analysis of acidic drugs in the effluents of sewage treatment plants using liquid chromatography-electrospray ionization tandem mass spectrometry. J. Chromatogr. A., 952, 139-147 (2002).
11. Epps, D. E., Raub, T. J. and Kezdy, F. J.: A General, Wide-Range Spectrofluorometric Method for Measuring the Site-Specific Affinities of Drugs toward Human Serum Albumin. Anal. Biochem., 227: 342-350 (1995).
12. Kragh-Hanssen, U.: Ligand Binding sites (regions) of Human Serum Albumin. In Otagiri, M., Sugiyama, Y., Testa, B., Tillement, J. (Eds): Proceedings of the International Symposium on Serum Albumin & α1-Acid Glycoprotein from Basic Sciences to Clinical Applications, 2000, pp. 55-66.
13. Fetter, J., Leiton, M. and Zatón, A.: The binding of Benzopyranes to Human Serum Albumin. A structure-Affinity Study. J Protein Chem., 17: 115-119 (1998).
14. O'Reilly, R. A.: Interaction of Several Coumarin Compounds with Human and Canine Plasma Albumin. Mol. Pharm., 7: 209-218 (1971).
15. Yuan, H. and Pawliszyn, J.: Application of Solid-Phase Microextraction in the Determination of Diazepam Binding to Human Serum Albumin. Anal. Chem., 73: 4410-4416 (2001).
16. Kragh-Hansen, U.: Relations between high-affinity binding sites for L-tryptophan, diazepam, salicylate and Phenol Red on human serum albumin. Biochem. J., 209: 135-142 (1983).